Keith Fred Silverman

age ~65

from New York, NY

Get Report

Also known as:

Keith F Silverman
Keith Dr Silverman
Keith S Silverman
Keith L Silverman
Keith F Siverman
Keith Silvermann
Silverman D Keith

Phone and address:: 260 W End Ave APT 8C, New York, NY 10023

Connected to:

Keith Silverman Phones & Addresses

260 W End Ave APT 8C, New York, NY 10023
40 86Th St, New York, NY 10024 • 2128775370
10 Sheridan Dr, Short Hills, NJ 07078 • 9732580233 • 9732584051
Millburn, NJ
Massapequa, NY
Denver, CO
Stamford, CT

Languages

English

Specialities

Dentistry

Resumes

Professional Engineer Seeking Consulting Position In Forensics Engineering

view source

Location:

3 Delano Ct, Morristown, NJ

Industry:

Oil & Energy

Work:

Professional Engineer Seeking Consulting Position In Forensics Engineering
Major Oil Company Inc Jun 2000 - Dec 2012
Global Operations Acceptance
Major Oil Company Inc Jun 2000 - Dec 2012
Export Controls Coordinator
Major Oil Company Inc Dec 1979 - Jun 2000
Facility Electrical and Instrumentation Engineer
Princeton Plasma Physics Laboratory (Pppl) Sep 1975 - Dec 1979
Neutral Beam Section

Education:

New Jersey Institute of Technology 1984 - 1988
Masters, Master of Arts, Management, Engineering Worcester Polytechnic Institute 1971 - 1975
Bachelors, Electrical Engineering

Skills:

Quality Assurance
Onshore
Petroleum
Process Control
Gas
Instrumentation
Engineering
Facilities Management
Electrical Engineering
Process Improvement
Microsoft Office
Problem Solving
Project Coordination
Sharepoint
Infopath

Languages:

English

Certifications:

Professional Engineer State of Nj
Nj State Board of Professional Engineers and Land Surveyors

Property Manager

view source

Location:

121 Essex Ave, Bloomfield, NJ 07003

Industry:

Real Estate

Work:

First Service Residential
Property Manager
Bella Condominiums/Atlantic City
Property Manager
First Day Consulting Oct 2008 - Oct 2012
Business Broker
Gothlem Real Estate Mar 2004 - Oct 2006
Property Manager
Mobile Video & Film Production Dec 1988 - Dec 2005
Chief Executive Officer and Founding Partner

Education:

Montclair State University 1976 - 1980
Bachelors, Bachelor of Arts, Business, Communications

Skills:

Property Management
Entrepreneur
Contract Negotiation
New Business Development
Sales
Real Estate
Due Diligence
Negotiation
Business Planning
Investments
Small Business
Sales Management
Customer Service
Business Development
Budgets
Strategic Planning
Mergers and Acquisitions
Marketing
Management
Financial Analysis
Investment Properties
Team Building
Operations Management
Retail

Owner

view source

Location:

40 west 86Th St, New York, NY 10024

Industry:

Medical Practice

Work:

Dr Keith Silverman 1988 - 2008
Dentist
Keith Silverman Dmd 1988 - 2008
Owner

Education:

Brandeis University 1977 - 1981

Languages:

English

Senior Vice President Of Global Operations, Quality And Ehs

view source

Location:

Bridgewater, NJ

Industry:

Chemicals

Work:

Ashland Inc Feb 2017 - Nov 2018
Vice President of Global Operations, Quality and Ehs
Ashland Inc Feb 2017 - Nov 2018
Senior Vice President of Global Operations, Quality and Ehs
Ashland Inc Feb 2014 - Feb 2017
Vice President Ehs, Quality and Regulatory Affairs
American Institute of Chemical Engineers Feb 2014 - Feb 2017
Ccps Advisory Board Member
Socma Feb 2014 - Feb 2017
Member Board of Directors

Education:

Columbia Business School 2014 - 2016
Rutgers University 1985 - 1989
Bachelors, Bachelor of Arts, Biology, Microbiology, Biochemistry Bergen Catholic High School 1981 - 1985
University of Medicine and Dentistry of New Jersey
University of Medicine and Dentistry of New Jersey
Master of Public Health, Masters New Jersey Institute of Technology
Doctorates, Doctor of Philosophy, Health Science Rutgers University
Master of Public Health, Masters

Skills:

Ehs
Risk Assessment
Hazardous Materials
Hazardous Waste Management
Occupational Health
Emergency Services
Process Safety
Environmental Awareness
Policy
Emergency Management
Toxicology
Environmental Compliance
Sustainability
Industrial Safety
Firefighting
Pharmaceutical Industry
Environmental Policy
Environmental Health
Public Safety
Regulatory Affairs
Product Stewardship
Public Health
Gis
Chemical Industry
Auditing
Fda Gmp
Manufacturing
Manufacturing Operations
Manufacturing Operations Management

Name / Title

Company / Classification

Phones & Addresses

Keith Silverman
President

Stepping Stone Video Productions Inc
Whol Brick/Stone Material

45 E 21 St, New York, NY 10010

Keith Silverman
Principal

Goldshield Team LLC
Business Consulting Services

2 Bath Dr, Millstone, NJ 08844

Keith F. Silverman
Owner, Family And General Dentistry

Keith F Silverman DMD
Dentist's Office

40 W 86 St, New York, NY 10024
2128775370

Keith Fred Silverman

Keith Silverman DMD
Cosmetic Dentist · Dentures · Dentists · Periodontics · Endodontics · Tmj

40 W 86 St, New York, NY 10024
2128775370

Keith Silverman
President

MOBILE VIDEO PRODUCTIONS, INC
Television & Motion Picture Production · Motion Picture/Tape Distribution Equipment Rental/Leasing · Video Production · Motion Picture & Video Production

636 6 Ave, New York, NY 10011
636 Ave Of The Americas, New York, NY 10011
45 W 21 St, New York, NY 10010
2126865926, 2129249616

Us Patents

Hiv Integrase Inhibitors
view source
US Patent:

6403347, Jun 11, 2002
Filed:

Oct 25, 1999
Appl. No.:

09/355692
Inventors:

Gerald F. Bills - Clark NJ
Russell B. Lingham - Watchung NJ
Ali Shafiee - Westfield NJ
Keith C. Silverman - Somerset NJ
Sheo Bux Singh - Edison NJ
Deborah L. Zink - Manalapan NJ
Fernando Pelaez - Madrid, ES
Ana M. Teran - Madrid, ES
Assignee:

Merck Co., Inc. - Rahway NJ
International Classification:

A61K 3135
US Classification:

435171, 514450, 514452, 514454, 514455, 549348, 549349, 549389
Abstract:

Natural products such as certain chaetochromins are described. These compounds are useful in the inhibition of HIV integrase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.

Hiv Integrase Inhibitors
view source
US Patent:

6541515, Apr 1, 2003
Filed:

Aug 9, 2001
Appl. No.:

09/925114
Inventors:

Sheo Bux Singh - Edison NJ
Hiranthi Jayasuriya - Edison NJ
Ziqiang Guan - Edison NJ
Keith C. Silverman - Somerset NJ
Russell B. Lingham - Watchung NJ
Anne W. Dombrowski - East Brunswick NJ
Daria J. Hazuda - Doylestown PA
Jon D. Polishook - Cranford NJ
Assignee:

Merck Co., Inc. - Rahway NJ
International Classification:

A61K 31215
US Classification:

514510, 514529, 514557, 514561, 560119, 562501
Abstract:

Compounds useful in the inhibition of HIV integrase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines are described. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described. The culture Cytospora sp. MF 6608 (ATCC PTA-1691) is also disclosed, as well as processes for making a compound of the present invention employing the culture.

Hiv Integrase Inhibitors
view source
US Patent:

61243272, Sep 26, 2000
Filed:

Jul 27, 1998
Appl. No.:

9/123180
Inventors:

Keith C. Silverman - Somerset NJ
Russell B. Lingham - Watchung NJ
Sheo Bux Singh - Edison NJ
Deborah L. Zink - Manalapan NJ
Ana Teran - Madrid, ES
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

C07C 6984
A61K 31235
US Classification:

514352
Abstract:

Natural products such as certain dimerized hydroxyphenylundecanes are described. These compounds are useful in the inhibition of HIV integrase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.

Inhibitors Of Farnesyl-Protein Transferase
view source
US Patent:

54362636, Jul 25, 1995
Filed:

Mar 22, 1994
Appl. No.:

8/216110
Inventors:

Sheo B. Singh - Edison NJ
Barry A. Katz - Chapel Hill NC
Russell B. Lingham - Watchung NJ
Isabel Martin - Madrid, ES
Keith C. Silverman - Somerset NJ
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

A61K 31335
C07D31300
US Classification:

514450
Abstract:

The present invention is directed to compounds which inhibit farnesyl-protein transferase (FPTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.

Inhibitor Compounds Of Farnesyl-Protein Transferase And Chemotherapeutic Compositions Containing The Same, Produced By Strain Atcc 55532
view source
US Patent:

56270577, May 6, 1997
Filed:

Mar 6, 1996
Appl. No.:

8/611700
Inventors:

Sheo B. Singh - Edison NJ
George M. Garrity - Westfield NJ
Olga Genillourd - Madrid, ES
Russell B. Lingham - Watchung NJ
Isabel Martin - Madrid, ES
Keith C. Silverman - Somerset NJ
Deborah L. Zink - Manalapan NJ
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

C12N 120
C12P 106
C12P 3300
US Classification:

435135
Abstract:

The present invention is directed to compounds which inhibit farnesyl-protein transferase (FPTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras. Furthermore, Actinoplanes sp. ATCC 55532 and Streptomces sp. ATCC 55550 are microorganisms which are capable of producing the disclosed compounds which are classified as carboxylic acid esters. In addition a method for preparing the compounds is disclosed which includes cultivating strain ATCC 55532 or strain ATCC 55550. The strains are independently capable of producing the carboxylic acid ester compounds.

Hiv Integrase Inhibitors
view source
US Patent:

61107166, Aug 29, 2000
Filed:

Feb 4, 1998
Appl. No.:

9/018684
Inventors:

Russell B. Lingham - Watchung NJ
Ali Shafiee - Westfield NJ
Keith C. Silverman - Somerset NJ
Ana M. Teran - Madrid, ES
Sheo Bux Singh - Edison NJ
Deborah L. Zink - Manalapan NJ
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

A61K 3135
C07D31178
C07D32110
US Classification:

435171
Abstract:

Natural products such as certain chaetochromins are described. These compounds are useful in the inhibition of HIV integrase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.

Inhibitors Of Farnesyl Protein Transferase Or Prodrugs Thereof
view source
US Patent:

54201578, May 30, 1995
Filed:

Dec 16, 1991
Appl. No.:

7/808124
Inventors:

Sheo B. Singh - Edison NJ
Gerald F. Bills - Roselle NJ
Russell B. Lingham - Watchung NJ
Keith C. Silverman - Somerset NJ
Deborah L. Zink - Manalapan NJ
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

A01N 4332
C07D30702
C07D30734
US Classification:

514452
Abstract:

This invention relates to pharmaceutical compounds of structural formulae (I) and (II): ##STR1## and compositions and methods of treatment utilizing these compounds to inhibit farnesyl protein transferase and farnesylation of the oncogene protein Ras.

Inhibitors Of Farnesyl-Protein Transferase
view source
US Patent:

57894388, Aug 4, 1998
Filed:

Sep 5, 1997
Appl. No.:

8/924557
Inventors:

Sheo B. Singh - Edison NJ
Russell B. Lingham - Watchung NJ
Keith C. Silverman - Somerset NJ
Deborah L. Zink - Manalapan NJ
Isabel Martin - Madrid, ES
Fernando Pelaez - Madrid, ES
Manuel Sanchez - Madrid, ES
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

A61K 31365
C07D49306
US Classification:

514453
Abstract:

The present invention is directed to steroidal or terpenoidal compounds which inhibit farnesyl-protein transferase (FPTase). The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and treatment of cancer.